Bortezomib for anti-NMDAR encephalitis following daclizumab treatment in a patient with multiple sclerosis. (2021)
Attributed to:
A next-generation MRI brain imaging platform for dementia research: from microstructure to function
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1136/bmjno-2020-000096
PubMed Identifier: 34079936
Publication URI: http://europepmc.org/abstract/MED/34079936
Type: Journal Article/Review
Volume: 3
Parent Publication: BMJ neurology open
Issue: 1
ISSN: 2632-6140